Adage Capital Partners Gp, L.L.C. Guardant Health, Inc. Transaction History
Adage Capital Partners Gp, L.L.C.
- $51.6 Billion
- Q1 2025
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Guardant Health, Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 846,749 shares of GH stock, worth $33.2 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
846,749
Previous 279,800
202.63%
Holding current value
$33.2 Million
Previous $8.55 Million
322.03%
% of portfolio
0.07%
Previous 0.02%
Shares
11 transactions
Others Institutions Holding GH
# of Institutions
392Shares Held
121MCall Options Held
1.43MPut Options Held
2.37M-
Vanguard Group Inc Valley Forge, PA12.1MShares$473 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$440 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT5.44MShares$213 Million8.11% of portfolio
-
Capital International Investors Los Angeles, CA5.15MShares$202 Million0.04% of portfolio
-
Baillie Gifford & CO5.06MShares$198 Million0.19% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $4B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...